A phase II, open label, uncontrolled, multi-center study to support annual strain update and to evaluate safety and immunogenicity of a surface antigen, inactivated, adjuvanted influenza vaccine, formulation 2007-2008, when administered to subjects aged 18-64 years affected by chronic diseases.

Trial Profile

A phase II, open label, uncontrolled, multi-center study to support annual strain update and to evaluate safety and immunogenicity of a surface antigen, inactivated, adjuvanted influenza vaccine, formulation 2007-2008, when administered to subjects aged 18-64 years affected by chronic diseases.

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Jan 2012

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Novartis
  • Most Recent Events

    • 04 Jan 2012 Actual end date Jul 2007 added as reported by ClinicalTrials.gov.
    • 04 Jan 2012 Actual patient number 52 added as reported by ClinicalTrials.gov.
    • 05 Sep 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top